Protein kinase A, inhibition

Neylon, C. B., D Souza, T., and Reinhart, P. H. 2004. Protein kinase A inhibits intermediate conductance Ca2+ -activated K+ channels expressed in Xenopus oocytes. Pflugers Arch. 448 613-620... 

Luo, M., S. M. Jones et al. 2004. Protein kinase A inhibits leukotriene synthesis by phosphorylation of 5-lipoxygenase on serine 523. J Biol Chem 279(40) 41512-41520. 

The antisense oligonucleotide LErafAON against the serine/threonine kinase c-Raf has been tested in phase I clinical trials. The antisense oligonucleotides ISIS-5132, which also inhibits c-Raf, and ISIS-3521, which inhibits PKC, went through different phase clinical trials with solid tumour patients. Unfortunately, no objective responses occurred with these PKI. GEM-231, an oligonucleotide targeting the RIa subunit of protein kinase A is currently undergoing phase I/II clinical trials alone or in combination with traditional therapy for the treatment of solid cancers [3]. 

Sarcoplasmic calcium ATPase this enzyme utilizes the energy gained from hydrolysis of ATP to pump calcium from the cytosol into the stores of the sarcoplasmic reticulum. Its activity is negatively regulated by the closely associated protein phospholamban, and this inhibition is relieved upon phosphorylation of phospholamban by protein kinase A (PKA). 

Figure 6. A hypothetical scheme for the control of the number of active crossbridges in smooth muscle. Following the activation of a smooth muscle by an agonist, the concentrations of intermediates along the main route begins to build up transiently. This is shown by the thickened arrows. Also, cAMP is generated which is universally an inhibitor in smooth muscle. Cyclic AMP in turn combines with protein kinase A, which accounts for most of its action. The downstream mechanisms, however, are not well worked out and at least three possibilities are likely in different circumstances. First, protein kinase A is known to catalyze the phosphorylation of MLCK, once phosphorylated MLCK has a relatively lower affinity for Ca-calmodulin so that for a given concentration of Ca-calmodulin, the activation downstream is reduced. The law of mass action predicts that this inhibition should be reversed at high calcium concentrations. Other cAMP inhibitory mechanisms for which there is evidence include interference with the SR Ca storage system, and activation of a MLC phosphatase.

Not only is phosphorylase activated by a rise in concentration of cAMP (via phosphorylase kinase), but glycogen synthase is at the same time converted to the inactive form both effects are mediated via cAMP-dependent protein kinase. Thus, inhibition of glycogenolysis enhances net glycogenesis, and inhibition of glycogenesis enhances net glycogenolysis. Furthermore,... 

Recent evidence indicates that the 5-HT transporter is subject to post-translational regulatory changes in much the same way as neurotransmitter receptors (Blakeley et al. 1998). Protein kinase A and protein kinase C (PKC), at least, are known to be involved in this process. Phosphorylation of the transporter by PKC reduces the Fmax for 5-HT uptake and leads to sequestration of the transporter into the cell, suggesting that this enzyme has a key role in its intracellular trafficking. Since this phosphorylation is reduced when substrates that are themselves transported across the membrane bind to the transporter (e.g. 5-HT and fi -amphetamine), it seems that the transport of 5-HT is itself linked with the phosphorylation process. Possibly, this process serves as a homeostatic mechanism which ensures that the supply of functional transporters matches the demand for transmitter uptake. By contrast, ligands that are not transported (e.g. cocaine and the selective serotonin reuptake inhibitors (SSRIs)) prevent the inhibition of phosphorylation by transported ligands. Thus, such inhibitors would reduce 5-HT uptake both by their direct inhibition of the transporter and by disinhibition of its phosphorylation (Ramamoorthy and Blakely 1999). 

Relationship between flavonoid structure and inhibition of phos-phatidylinositol 3-kinase a comparison with tyrosine kinase and protein kinase C inhibition Biochemical Pharmacology 53, 1649-57. 

NARDINI M, SCACCINI c, PACKER L and VIRGILI F (2000) In vivo inhibition of the activity of phosphorylase kinase, protein kinase C and protein kinase A by caffeic acid and a procyanidin rich pine bark (Pinus maritima) extract Biochimica Biophysica Acta 1474, 219-25. 

TASINATO A D, BOISCOBOINIK D, BARTOLI G M, MARONi p and Azzi A (1995) d-a-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its ntioydd ait xo eriie% Proceedings National Academy Sciences USA 92, 12190-4. 

The cAMP molecule serves as the second messenger, which carries out the effects of the hormone inside the cell. The primary function of cAMP is to activate protein kinase A. This kinase then attaches phosphate groups to specific enzymatic proteins in the cytoplasm. The phosphorylation of these enzymes enhances or inhibits their activity, resulting in the enhancement or inhibition of specific cellular reactions and processes. Either way, cellular... 

The inhibition of PDE1 by protein kinase A could serve to sustain intracellular cAMP levels under certain physiological conditions. 

Sanders Did you ever look to see whether indomethacin (i.e. prostaglandin inhibition) decreases coupling between these Ca2+ waves and activation of BK channels Perhaps this is your time delay. Production of prostaglandin should activate protein kinase A because of cAMP production, and this will increase BK open probability. 

Phospholamban is a protein that inhibits the SERCA pumps by decreasing their affinity for Ca2+. It can be phosphorylated by protein kinase A, for instance in response to /1-adrenoceptor activation, resulting in inhibition of its effects and enhanced SERCA activity. The effects of phospholamban on contraction depend on the relative importance of Ca2+ uptake or release in the smooth muscle in... 

This method has been applied in the enantioselective synthesis of d-erythro-sphingosine and phytosphingosine. Sphingosine became an important substance for studying signal transduction since the discovery of protein kinase C inhibition by this compound.48 Many efforts have been made to synthesize sphingosine and its derivatives.49 Kobayashi et al. reported another route to this type of compound in which a Lewis acid-catalyzed asymmetric aldol reaction was a key step. 

Mercuric chloride has also been shown to inhibit the enzymatic activity of soluble protein kinase A from mice brain, apparently by binding to sulphydryl groups of the enzyme [111]. The inhibition was of a non-competitive type with respect to HI histone. 

Figure 6.15. Structures of some protein kinase C inhibitors. Staurosporine is a potent inhibitor of protein kinase C, but is not selective. Some derivatives of protein kinase C, such as Ro31-8220 and Ro31-8425, retain a potency similar to that of the parent molecule in protein kinase C inhibition, but are much more specific.

Chmura, S. J., Nodzenski, E., Weichselbaum, R. R., and Quintans, J., 1996, Protein kinase C inhibition induces apoptosis and ceramide production through activation of a neutral sphingomyelinase. Cancer Res. 56 2711-2714. 

Insulin activates PFK-2 (via the tyrosine kinase receptor and activation of protein phosphatases), which converts a tiny amovmt of fructose 6-phosphate to fructose 2,6-bisphosphate (F2,6-BP). F2,6-BP activates PFK-1. Glucagon inhibits PFK-2 (via cAMP-dependent protein kinase A), lowering F2,6 BP and thereby inhibiting PPK-1. 

---